Page last updated: 2024-09-04

cycloastragenol and Carcinogenesis

cycloastragenol has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akgün, İH; Bedir, E; Debeleç-Bütüner, B; Korkmaz, KS; Öztürk, MB; Tağ, Ö; Yetik-Anacak, G	1

Other Studies

1 other study(ies) available for cycloastragenol and Carcinogenesis

Article	Year
Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis. Steroids, 2018, Volume: 135 Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Dinoprostone; Humans; Inflammation; Male; NF-kappa B; Prostatic Neoplasms; Sapogenins; Signal Transduction; Transcription, Genetic; Triterpenes	2018

Article

Year

Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis.

Steroids, 2018, Volume: 135

Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Dinoprostone; Humans; Inflammation; Male; NF-kappa B; Prostatic Neoplasms; Sapogenins; Signal Transduction; Transcription, Genetic; Triterpenes

2018